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Recurrent cholesteatoma is relatively uncommon. Residual middle ear cholesteatomas account 
for most of the cases of recurrent disease. The limited role of microscopy in the visualization of 
tridimensional anatomic alterations of the temporal bone led to the use of endoscopic examination as 
an additional tool in the realm of ear surgery. Endoscopy has significantly aided in the management 
of chronic cholesteatomatous otitis media and in the prevention of recurrent disease.
Objective: To review the literature and assess the relevance of endoscopy in the surgical treatment 
of cholesteatomas and in the prevention of relapsing lesions.
Method: Searches on databases MedLine and LILACS were carried out between March and June of 
2011 to select studies in which endoscopy was used in the management of cholesteatomas.
Results: Three studies comparing surgery aided by endoscopy and surgery performed with the aid 
of a microscope met the inclusion criteria.
Conclusion: Endoscopy has positively impacted the management of cholesteatomas and should 
be used in cholesteatoma surgery.
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INTRODUCTION
Schuknecht1 described cholesteatomas as collec-
tions of foliated keratin in the middle ear or any aerated 
area of the temporal bone originated from keratinized 
epithelium.
In 1874, Jean Petit described the first successful 
surgical intervention on the mastoid. Since then, the 
management of chronic cholesteatomatous otitis media 
(CCOM) has been imminently surgical2.
Surgery is required to tackle the continuous growth 
of cholesteatomas, associated bone resorption, involve-
ment of sensory organs, and potentially fatal intra and 
extracranial complications.
In the early 1950s, Wüllstein3 and Zöllner4 set the 
basic principles of tympanoplasty and established three 
basic objectives in chronic ear surgery:
•	 Eradicate disease;
•	 Preserve or restore auditory mechanics;
•	 Maintain, whenever possible, the anatomy of 
the temporal bone.
Various approaches based on these concepts were 
developed, such as tympanoplasty with canal wall up 
mastoidectomy and variants of canal wall down mastoi-
dectomy5-7.
The approaches to cholesteatomatous middle ear 
include basically tympanoplasty, canal wall up (CWU) 
and canal wall down (CWD) mastoidectomy7-8.
The choice of surgery to treat CCOM is based on 
complex criteria and a number of factors such as patient 
age, extent of involvement, middle ear mucosa status, 
anatomic peculiarities, auditory acuity, and social factors 
affecting patient follow-up7-8.
The most significant concern in the postoperative 
follow-up of patients submitted to any of the procedures 
mentioned above is recurrence of cholesteatoma and 
onset of potential associated complications.
Relapse may occur in cases of residual cholestea-
toma or recurrent cholesteatoma.
Residual cholesteatoma has been defined as relap-
sing disease originated from remnants of cholesteatoma 
left on the site of surgery9. Prevention of residual choles-
teatoma requires meticulous removal of the entire disease 
in the first procedure5.
According to Sheehy et al.10, the term “recurrent” 
applies to lesions stemming from epithelial migration 
secondary to graft continuity defect and originated from 
tympanic membrane retraction pouches.
The limited role of microscopy in the visualization 
of tridimensional anatomic alterations of the temporal 
bone led to the use of endoscopic examination as an 
additional tool in the realm of ear surgery. Endoscopy 
has significantly aided in the management of chronic 
cholesteatomatous otitis media and in the prevention of 
recurrent disease.
This study aimed to assess, through a systematic 
review, the importance of endoscopic examination 
of the ear in the prevention of recurring disease and 
in the treatment of chronic cholesteatomatous otitis 
media.
METHOD
Literature searches were carried out between March 
and June of 2011 on databases MedLine (National Library 
of Medicine) and LILACS (Literature on Health Sciences 
from Latin America and the Caribbean). Priority was 
given to studies on the application and impact of ear 
endoscopy as an ancillary method in the management 
of CCOM. The Cochrane Reviews Handbook11 was used 
to pick the search strategy adopted in this study. Search 
keywords can be seen on Tables 1 and 2. The search 
was limited to papers published between January of 1985 
and June of 2011.
#1 cholesteatoma #5 (#1 and #3)
#2 residual cholesteatoma #6 (#2 and #3)
#3 *endoscopy
Table 1. Keywords and used combinations.
#1 colesteatoma #5 (#1 and #3)
#2 colesteatoma residual #6 (#2 and #3)
#3 *endoscopia
Table 2. Keywords in Portuguese and used combinations
This study included original papers from studies 
done on adult (age > 19 years) or pediatric popula-
tions, meta-analyses, systematic reviews, comparative 
or experimental cohort studies published between 
January of 1985 and June of 2011 (written in English, 
French, or Portuguese) on the aspects related to the 
epidemiology, diagnosis, and treatment of residual 
cholesteatoma associated with endoscopic exami-
nation of the ear. Case reports, letters to the editor, 
papers published in meeting proceedings, and papers 
in which the analyzed sample was not statistically 
significant were excluded. The selected original 
papers were analyzed for compliance with the crite-
ria described above. The references of the selected 
papers were used to locate papers not found in the 
initial search.
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Data on authors, clinical diagnosis, participants 
(number of enrolled subjects and group allocations), 
participant age range, pattern of CCOM, details pertaining 
to the chosen surgical approach, statistical analysis used 
to assess impact, outcomes reported during surgery, and 
pattern of recurrence of the studied disease were sum-
marized for the selected papers.
RESULTS
The initial database search listed 140 referen-
ces, 106 of which resulting from the combination of 
keywords “cholesteatoma” and “endoscopy”; 25 papers 
were listed from the combination of terms “residual 
cholesteatoma” and “endoscopy”. Twenty-three papers 
appeared twice in the cross-referencing of all searches; 
108 papers were left after the duplicates were remo-
ved. Thirty-seven of these papers were pre-selected 
based on the contents of their titles and the established 
inclusion and exclusion criteria. The abstracts of these 
papers were read and 27 were found to be case reports, 
non-comparative series reports, papers that could not 
be located, or papers written in languages other than 
English, Portuguese or French.
Seven of the remaining papers selected based 
on the inclusion criteria and method were excluded for 
describing case reports (Table 3). Three papers looked 
into the use of endoscopy in cholesteatoma surgery 
against traditional surgery with the aid of a microscope 
(Table 4).
In order to verify cases of relapsing disease, the 
subjects in both groups underwent endoscopic mini-
mally invasive procedures between 13 and 19 months 
after the original procedure. Significant differences 
were seen between groups. Forty-seven percent of the 
individuals in group I had recurrent cholesteatomas, 
against six percent of the subjects in group II. The 
comparison also revealed that subjects in group II had 
minor residual cholesteatomas - small or pearl-shaped 
cholesteatomas - whereas 10% of the individuals in 
group I required additional surgery due to the size of 
their relapsing lesions.
El Meselaty et al.18 studied 82 patients aged 
between six and 58 years with acquired cholesteatoma. 
The subjects were divided into four groups according 
to the procedures they were offered.
•	 Group I (n = 23) subjects were submitted 
to traditional CWD mastoidectomy with-
out verification of residual disease during 
surgery;
•	 Group II (n = 21) subjects underwent CWD 
mastoidectomy with endoscopic intraopera-
tive verification and removal, if needed, of 
residual disease;
•	 Group III (n = 21) individuals were offered 
traditional CWU mastoidectomy;
•	 Group IV (n = 21) individuals were submitted 
to CWD mastoidectomy with the aid of endo-
scopic examination.
The analysis of recurrence rates was based on the 
data gathered during a mean follow-up of 19.20 (± 8.7) 
months. The author included in his study only the 
patients who had been followed up for at least a year. 
Subjects in group I has recurrence rates of five percent, 
against 26% of individuals in group III; no recurrence 
was observed in the patients operated with the aid of 
an endoscope.
Ayache et al.19 published a retrospective study 
including 350 patients aged between three and 87 
years. The subjects underwent tympanoplasty, trans-
meatal approach mastoid surgery, CWD or CWD 
mastoidectomy depending on the extent and location 
of disease. Involvement of the epitympanum was 
observed in 247 individuals. They were randomly 
assigned to two groups, namely groups A (n = 167) 
- microscope-aided procedures - and B (n = 80) - 
endoscope-aided surgery. No significant differences 
were reported between groups. However, the authors 
stressed that endoscope-aided resections resulted in 
minor clinically inactive residual lesions, thus rein-
forcing the quality of endoscope-aided cholesteatoma 
removal.
Table 3. Reason for paper exclusion.
1993, Yanagihara et al.5 Case series report; non-comparative study;
2010, Yang et al.12 Case series report; non-comparative study;
1996, Gyo et al.13 Case series report; non-comparative study;
1999, Tarabichi et al.14 Case series report; non-comparative study;
1997, Tarabichi et al.15 Case series report; non-comparative study;
2002, Bad-El-Dine16 Case series report; non-comparative study;
2008, Barakate et al.17 Case series report; non-comparative study.
Thomassin et al.9 studied 80 patients with acquired 
cholesteatoma randomly divided regardless of extent 
of involvement or type of planned intervention, as 
follows:
•	 Group I (n = 44), submitted to microscope-
aided CWD or CWU mastoidectomy;
•	 Group II (n = 36), submitted to similar 
procedures as described above with the 
aid of endoscopic examination of the ear 
to detect residual cholesteatoma on the site 
of surgery.
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DISCUSSION
In the opinion of the authors of this study, the 
distinction between recurrent and residual cholestea-
toma is of fundamental importance to understand the 
mechanism by which relapsing disease is formed and 
controlled.
The site of recurrence may offer insights into the 
contributing factors for cholesteatoma formation.
The literature20 reports varying incidence rates of 
recurrent cholesteatoma, but the topography of invol-
vement has been well established. The most commonly 
involved areas in decreasing order are the epitympanic 
recess, the tympanic cavity, the mastoid antrum, and the 
mastoid20.
Recurrent cholesteatomas pose threats only 
when tympanoplasty is performed to manage initial 
disease. Many authors have reported incidence rates 
under five percent when the following measures 
were considered: prevent the formation of adhesions 
between the medial surface of the graft and the bare 
bone surface of the epitympanum, mesotympanum, 
and facial recess; repair continuity defects of the bone 
portion of the ear canal and ensure good aeration of 
the middle ear, particularly in cases of eustachian tube 
disorder10.
Sheehy et al.10 described a procedure in which 
a large opening on the facial recess is made to pass a 
small plastic plate through the posterior tympanotomy to 
coat the exposed bone tissue and prevent graft adhesion. 
Bone defects of the outer ear canal and epitympanic 
recess can be repaired with chips of tragal cartilage. 
Reported incidence rates dropped from 21% to five 
percent after these measures were taken. Yanagihara 
et al.5 described good outcomes with the use of artifi-
cial dura mater fixated with fibrin glue to repair large 
scutum bone defects.
Despite its relatively low incidence rate and the 
declining rates of recurrent cholesteatoma, residual cho-
lesteatomas of the middle ear are strongly correlated with 
recurrent disease. In reoperated patients, Shelton and 
Sheehy21 found residual cholesteatoma in one third of 
the subjects offered microscope-aided surgery.
Sheehy et al.10 looked into 303 revision surgery 
patients and identified relapsing disease in 36% of the 
subjects submitted originally to CWU mastoidectomy. The 
authors also reported higher incidence rates in children 
and confirmed the middle ear as the preferred site of 
involvement, followed by the epitympanum and, less 
commonly, the mastoid.
Smyth22 described an incidence of 13% of recur-
rent cholesteatomas in the epitympanum in 97 cases 
in which cholesteatomas were believed to have been 
completely removed. Residual cholesteatoma was seen 
in 12% of 208 examined middle ears. The late postope-
rative examination of children unsuspected for recur-
rent disease revealed an incidence of 23% of residual 
cholesteatoma.
Table 4. Comparative summary of relevant papers.
Author Thomassin et al.9 El Meselaty et al.18 Ayache et al.19
Diagnosis Primary/secondary acquired cholesteatoma.
Primary/secondary acquired 
cholesteatoma.
Primary/secondary acquired 
cholesteatoma.
Participants
80 (2 groups - 44 submitted to 
microscope-aided surgery/36 to 
endoscope-aided surgery).
82 (4 groups - 23 offered CWU 
mastoidectomy/21 endoscope-aided 
CWD mastoidectomy/21 CWD 
mastoidectomy/21 endoscope-aided 
CWU mastoidectomy).
247 (167 submitted to microscope-aided 
surgery/80 to endoscope-aided surgery).
Age 60 adults/20 children. 6-58 years. 3-87 years.
Notes on the study
Patients were randomly assigned 
to groups regardless of extent of 
disease or type of surgery.
Patients were randomly distributed in 
groups based on type of surgery.
This retrospective study included 247 
individuals with epitympanum involvement. 
Patients were randomly assigned to groups 
regardless of type of surgery.
Program details
All subjects underwent 
endoscope-aided minimally 
invasive surgery between 13 
and 19 months after the initial 
procedure.
Mean follow-up of 19.20 (± 8.7) 
months; only patients followed up for 
at least a year were included.
40% of the subjects in group I and 45% of 
the individuals in group II were reoperated 
one year after the first procedure; they 
were picked randomly. The other subjects 
were followed up conservatively.
Findings
Recurrent cholesteatoma in 
47% of the cases vs. 6% among 
members of the group submitted 
to endoscope-aided procedures.
No cases detected in patients 
operated with the aid of an endoscope 
vs. 5-26% recurrent disease in patients 
operated with the aid of a microscope.
No significant differences between groups; 
importance of good disease removal in 
endoscope-aided procedure was stressed.
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Why are the incidence rates of postoperative 
residual cholesteatoma so high, and why are they found 
more commonly in the crevices of the middle ear and 
the epitympanic recess?
Initially, the lack of consensus on the choice 
between CWU or CWD mastoidectomy lied in the center 
of discussions on the management of cholesteatomas23. 
CWD mastoidectomy was claimed to result in a cavity 
conducive to otorrhea and constant postoperative care. 
By its turn, CWU mastoidectomy, still in development at 
that time, seemed to respect the anatomy of the middle 
ear at the expense of increased incidences of residual 
and recurrent cholesteatoma19.
Complete cholesteatoma removal is one of the 
main goals in the management of chronic middle ear 
processes. Ear microsurgery has developed signifi-
cantly since the introduction of surgical microscopes. 
Two of the main features of surgical microscopes are 
parallel optical route and linear optical axis. However, 
the middle ear and the mastoid are embedded in the 
temporal bone and form a complex tridimensional 
structure, with a number of barely accessible anatomic 
landmarks. The poor lighting and limited viewing of 
the site of surgery provided by surgical microscopes 
prevent lesions located in deep lateral recesses of 
the middle ear from being easily removed, possibly 
leading to increased rates of residual cholesteatoma12. 
Conventional surgical approaches, given the limits of 
microscope-aided procedures, often require the drilling 
of uninvolved areas to allow access to specific sinuses 
or recesses, thus harming the principle of conservatism 
in temporal bone surgery24.
Residual disease tends to develop in sites where 
access to cholesteatoma is impeded in primary surgery13. 
Certain regions of the middle ear such as the anterior epi-
tympanum and the supratubal recess, even after extensive 
mastoidectomy and exteriorization of the attic and the 
antrum, are difficult to access19. Despite the inherent risk 
of facial nerve injury, posterior tympanotomy provides 
access to the oval window and the facial recess, but fails 
to allow proper visualization of the deeper tympanic 
sinus during surgery9.
Donaldson et al.25 observed that the tympanic 
sinus, located medially to the facial nerve, may extend 
to well beyond the posterior margin of the fallopian 
canal. Thus, cleaning this anatomic site with any known 
instrument could be an extremely difficult task26. The 
longitudinal axis of the tympanic sinus runs perpendi-
cularly to the ear canal, rendering visualization with a 
microscope impossible. According to Thomassin9, only 
by using a 70-degree endoscope through the transcanal 
approach can surgeons attain god visualization of the 
tympanic sinus.
The regions difficult to access in CWU mastoi-
dectomy, particularly when the transmeatal approach is 
chosen, are the preferred sites for residual cholesteatoma.
The endoscopic transtympanic approach to the 
middle ear was originally described by Nomura27. Thomassin 
et al.9 described endoscopy-guided ear surgery as a com-
plementary technique to mastoid surgery.
Endoscopic visualization usually covers the entire 
tympanic ring and the ear canal in the same field of vision. 
Although microscopes offer tridimensional visualization, 
their field of vision is limited by the narrower portion 
of the ear canal. This hampers visualization and leads to 
constant manipulation of the microscope or the patient’s 
head during surgery14.
Endoscopy is an excellent addition to the tool-
set used to assess the middle ear, particularly when 
areas difficult to view using a microscope such as the 
tympanic sinus, facial recess, hypotympanum, epi-
tympanum, and supratubal recess are considered14,15. 
The removal of residual cholesteatomas in these sites 
is possible when specific ear endoscopy instruments 
are used9,26.
The steps described for endoscope-assisted sur-
gery are very similar among most authors. After the 
completion of traditional microscope-aided procedures, 
inspection with an endoscope is made in anatomic sites 
of difficult access. Using a 3-mm, 16-cm, 45° endoscope 
and the transcanal approach, Marchioni26 described 
excellent control of the medial border of the tympa-
nic sinus, oval window niche, junction of the styloid 
eminence and the jugular bulb, and the entire inferior 
retrotympanum and hypotympanum. Thomassin et al.9 
described total control of the tympanic cavity with 2.7 
mm, 0° and 70° endoscopes using the transcanal or 
transmastoid approaches.
However, some shortcomings of the endoscopic 
technique may limit its use in ear surgery. The lack of 
tridimensional visualization requires surgeons to be 
particularly careful when handling surgical equipment. 
Additionally, the surgeon has only one free hand and 
bleeding may render the procedure unviable14.
The use of ear endoscopy as an ancillary method 
during surgery improved the assessment of the cavity 
after the complete removal of the cholesteatoma with the 
aid of a microscope. Ayache et al.13 found evidences of 
residual tissue in the epitympanum and retrotympanum 
in 44% and 76% of the cases respectively. El-Meselaty 
et al.18 reported residual cholesteatoma in 50% of the 
patients submitted to CWU mastoidectomy. Badr-el-Dine16 
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reported an incidence rate of 23.8% in a series of 82 cases 
of CWU mastoidectomy.
The contributions of intraoperative ear endos-
copy in cholesteatoma surgery are evident. However, 
in practical terms, has endoscopy actually reduced the 
incidence of recurrent disease even in more conservative 
approaches?
Many authors have observed significant reduc-
tions on both incidence rates and extent of lesion when 
endoscopes were used. Yung28, M. Badr-el-Dine16, and 
Barakate & Bottrill17 reported incidence rates of residual 
cholesteatoma of 9.4%, 8.6%, and 15.78% respectively in 
revision surgery after CWU mastoidectomy.
Thomassin et al.9 compared endoscope-aided to 
traditional ear microsurgery and found reductions on 
the rates of residual cholesteatoma from 47% to 6% in a 
group offered intraoperative endoscopy followed up for 19 
months. A “third-look” procedure was required in 10% of 
the patients offered traditional surgery because of the size 
of their cholesteatomas. El-Meselaty et al18 did not report 
recurrence in patients operated with the aid of an endos-
cope, against recurrence rates of 26% and 5% in patients 
offered CWU and CWD mastoidectomy respectively.
Ayache et al.19 did not find significant differences 
between patients submitted to microscope-aided sur-
gery and subjects offered endoscope-aided procedures. 
However, the use of the endoscope produced clinically 
inactive pearl-shaped residual lesions, thus stressing the 
good quality of disease removal when ear endoscopy 
was used as an ancillary method.
The significant variability in the incidence of 
residual cholesteatoma may be explained by factors 
connected to surgeon experience and skill level, the 
time until revision surgery for residual cholesteatoma, or 
even the specific indication criteria each author used to 
choose CWU instead of CWD mastoidectomy. Another 
interesting aspect is that late revision surgery possibly 
yields higher and certainly more realistic recurrence 
incidence rates.
CONCLUSION
None of the papers considered in this study were 
randomized trials. Nonetheless, they described several 
advantages of using ear endoscopy in the management 
of cholesteatomatous chronic otitis media. Even when 
recurrence rates were not decreased, authors reported 
that recurrent cholesteatomas were more easily located 
and surgically managed in endoscope-aided procedures. 
Therefore, it appears that endoscopy should be incorpo-
rated in the daily practice of otology.
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